Fig. 1From: Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trialDisease-free survival rate in each arm; 3-year disease-free survival rates were 79.0% in arm A and 79.3% in arm B (p = 0.94, log-rank test)Back to article page